Stocks/ZYME

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

ZYME

↓ PDF (Pro)
Zymeworks Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$27.46
+2.92%today
MKT CAP
$2.0B
+1.3% · 1Y
Earnings History
+57.3%
+106.4%
+17.8%
-70.6%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$27.46
Low
$31.00
Analyst Mean
$40.08
High
$58.00
13 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E33.8x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-90.9%
5y Revenue CAGR-36.4%
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership1.3%
Institutional Ownership99.8%
Short % of Float9.31%
Days to Cover7.5d
1 Week-5.1%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
SMITH JEFFREY T L MD, FRCPOfficerSale9,310$22.67$0.21M2026-01-12
SMITH JEFFREY T L MD, FRCPOfficerOther17,666--2026-01-12
GALBRAITH KENNETH HARRYChief Executive OfficerSale30,424$22.67$0.69M2026-01-12
GALBRAITH KENNETH HARRYChief Executive OfficerOther64,000--2026-01-12
MOORE PAUL ANDREWOfficerSale9,560$22.67$0.22M2026-01-12
Top Holders
HolderType% HeldValueΔ SharesAs of
EcoR1 Capital, LLCinstitution36.46%$0.61B+0.00%2025-12-31
Rubric Capital Management LPinstitution9.13%$0.15B+22.07%2025-12-31
Blackrock Inc.institution7.29%$0.12B+15.19%2025-12-31
BVF Inc.institution6.25%$0.11B+0.00%2025-12-31
Perceptive Advisors Llcinstitution5.18%$0.09B+56.02%2025-12-31
Morgan Stanleyinstitution4.12%$0.07B-34.92%2025-12-31
Vanguard Group Incinstitution3.70%$0.06B+8.09%2025-12-31
Siren, L.L.C.institution2.67%$0.04B+100.00%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund2.62%$0.04B+7.84%2025-12-31
Deutsche Bank AGinstitution2.53%$0.04B+3.30%2025-12-31
iShares Trust-iShares Russell 2000 ETFfund1.92%$0.03B-0.19%2026-03-31
Dimensional Fund Advisors LPinstitution1.84%$0.03B-2.66%2025-12-31
iShares Trust-iShares Biotechnology ETFfund0.84%$0.01B-2.49%2026-03-31
Fidelity Salem Street Trust-Fidelity Small Cap Index Fundfund0.76%$0.01B-1.46%2026-01-31
TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fundfund0.67%$0.01B-1.87%2026-01-31
iShares Trust-iShares Russell 2000 Growth ETFfund0.64%$0.01B-2.40%2026-03-31
Fidelity Securities Fund-Fidelity Small Cap Growth Fundfund0.59%$0.01B+0.00%2026-01-31
DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Portfoliofund0.40%$0.01B+0.00%2026-01-31
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fundfund0.39%$0.01B+0.99%2026-02-28
BlackRock Funds-BlackRock Advantage Small Cap Core Fundfund0.35%$0.01B+13.29%2026-02-28
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total20
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for ZYME.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.